Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
about
An overview of cutaneous T cell lymphomasSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome.Monoclonal antibodies against cutaneous T-cell lymphomas.
P2860
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@ast
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@en
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@nl
type
label
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@ast
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@en
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@nl
prefLabel
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@ast
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@en
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@nl
P2093
P3181
P1476
Panoptic clinical review of th ...... as: Cutaneous T-cell lymphomas
@en
P2093
Dirk Huebner
Richard Lutes
Stefano Pileri
Vijayveer Bonthapally
P304
P3181
P356
10.1016/J.CRITREVONC.2015.12.018
P407
P577
2016-03-01T00:00:00Z